DAPAFLOZIN GM 2/500

Dapaflozin GM 2/500 Tablet is a powerful triple-combination antidiabetic medication designed to help control blood glucose levels in patients with Type 2 Diabetes Mellitus. It combines:

• Dapagliflozin (10 mg) – An SGLT2 inhibitor that promotes glucose excretion through urine.

• Glimepiride (2 mg) – A sulfonylurea that stimulates insulin release from pancreatic beta cells.

• Metformin (500 mg) – A biguanide that improves insulin sensitivity and lowers hepatic glucose production.

This combination works synergistically to provide comprehensive glycemic control, especially for patients not adequately managed with dual therapy.

Key Benefits:

• Efficient reduction in fasting and postprandial blood sugar

• Supports weight loss and may help lower blood pressure

• Reduces insulin resistance and boosts insulin activity

• Helps delay diabetes-related complications

• Once-daily dosing for better compliance